BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5114704)

  • 21. Further experiences with sodium fluoride treatment in osteogenesis imperfecta.
    Bilginturan N; Ozsoylu S; Yordam N
    Turk J Pediatr; 1982; 24(3):151-7. PubMed ID: 7147363
    [No Abstract]   [Full Text] [Related]  

  • 22. Familial hyperostosis of obscure nature.
    Isaacs M; Scheiner E; Dimich AB; Frimpter GW; Greenberg E; Alderman MH
    Metabolism; 1971 Oct; 20(10):910-26. PubMed ID: 5315404
    [No Abstract]   [Full Text] [Related]  

  • 23. Osteogenesis imperfecta. Therapeutic challenge.
    Pierog SH; Fontana VJ; Ferrara A
    N Y State J Med; 1969 Jan; 69(2):310-3. PubMed ID: 5251302
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma osteocalcin levels in patients with osteogenesis imperfecta.
    Castells S; Yasumura S; Fusi MA; Colbert C; Bachtell RS; Smith S
    J Pediatr; 1986 Jul; 109(1):88-91. PubMed ID: 3487629
    [No Abstract]   [Full Text] [Related]  

  • 25. Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.
    Cabral de Menezes Filho H; Rodrigues JM; Radonsky V; Della Manna T; Kuperman H; Steinmetz L; Dichtchekenian V; Damiani D; Setian N
    Horm Res; 2007; 68 Suppl 5():207-8. PubMed ID: 18174750
    [No Abstract]   [Full Text] [Related]  

  • 26. The results of sodium fluoride treatment in osteogenesis imperfecta.
    Bilginturan N; Ozsoylu S
    Turk J Pediatr; 1966 Jul; 8(3):129-42. PubMed ID: 5981967
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of synthetic salmon calcitonin in osteogenesis imperfecta.
    Castells S; Lu C; Baker RK; Wallach S
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):1-14. PubMed ID: 4203843
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
    Aström E; Magnusson P; Eksborg S; Söderhäll S
    Acta Paediatr; 2010 Dec; 99(12):1834-40. PubMed ID: 20726960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrophosphate levels and magnesium oxide therapy in osteogenesis imperfecta.
    Granda JL; Falvo KA; Bullough PG
    Clin Orthop Relat Res; 1977; (126):228-31. PubMed ID: 202425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Congenital osteogenesis imperfecta: clinical and biochemical evaluation in 80 children].
    Kulczycka H; Pronicka E; Ruszczak A; Stankiewicz B; Siwińska E; Sliwińska J; Lorenc R
    Pediatr Pol; 1987 Feb; 62(2):83-8. PubMed ID: 3615062
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of bone fragility].
    Schwarzenberg O
    Kinderarztl Prax; 1967 Oct; 35(10):447. PubMed ID: 5602236
    [No Abstract]   [Full Text] [Related]  

  • 32. [Osteogenesis imperfecta. Clinical, genetic and metabolic findings apropos of 2 cases].
    Aeschlimann MI; Herrera C; Aspillaga MJ; Palma J; Awad T
    Rev Med Chil; 1968 Mar; 96(3):133-7. PubMed ID: 5732743
    [No Abstract]   [Full Text] [Related]  

  • 33. [Application of growth hormone in osteoporosis (author's transl)].
    Kuhlencordt F; Lozano-Tonkin C; Kruse HP; Schneider C; Sommer E
    Klin Wochenschr; 1974 Dec; 52(23):1130-1. PubMed ID: 4444231
    [No Abstract]   [Full Text] [Related]  

  • 34. [Magnesium metabolism in the familial form of osteogenesis imperfecta].
    Milewicz A; Mihilewicz E
    Pol Tyg Lek; 1988 Nov; 43(46):1479-81. PubMed ID: 3253713
    [No Abstract]   [Full Text] [Related]  

  • 35. Idiopathic osteosclerosis. A report of 6 related cases.
    Russell WJ; Bizzozero OJ; Omori Y
    Radiology; 1968 Jan; 90(1):70-6. PubMed ID: 5635141
    [No Abstract]   [Full Text] [Related]  

  • 36. [Multiple pathologic fractures in osteogenesis imperfecta (author's transl)].
    Gerber BE; Jani L
    Orthopade; 1982 May; 11(3):101-8. PubMed ID: 7110712
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Calcium, phosphorus, and magnesium balance studies in homozygous thalassaemia.
    Lapatsanis P
    Arch Dis Child; 1973 Oct; 48(10):829. PubMed ID: 4749702
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peri-osteocytic calcium fixation under calcitonin treatment. Microradiographic study using automatic analysis of images in 8 cases of osteogenesis imperfecta].
    Duriez J; Flautre B
    Nouv Presse Med; 1975 Jan; 04(2):97-100. PubMed ID: 1138231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Magnesium metabolism in osteogenesis imperfecta tarda of the Loebstein type].
    Milewicz A; Zawada W
    Pol Tyg Lek; 1974 Sep; 29(36):1557-8. PubMed ID: 4422343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.